Global Radiopharmaceutical Market Growth 2020-2025
According to this study, over the next five years the Radiopharmaceutical market will register a 8.9%% CAGR in terms of revenue, the global market size will reach $ 8076 million by 2025, from $ 5737.8 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Radiopharmaceutical business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Radiopharmaceutical market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Radiopharmaceutical, covering the supply chain analysis, impact assessment to the Radiopharmaceutical market size growth rate in several scenarios, and the measures to be undertaken by Radiopharmaceutical companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Actinium-225
Lutetium-177
Radium-223
Holmium-166
Other
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Oncology
Cardiology
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Bracco Imaging
Jubilant Pharma
Bayer
Nordion
Triad Isotopes
Mallinckrodt
GE Healthcare
Lantheus
China Isotope & Radiation
IBA Group
Eli Lilly
Dongcheng
SIEMENS
Navidea
Advanced Accelerator Applications
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Radiopharmaceutical consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Radiopharmaceutical market by identifying its various subsegments.
Focuses on the key global Radiopharmaceutical manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Radiopharmaceutical with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Radiopharmaceutical submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Radiopharmaceutical Consumption 2015-2025
2.1.2 Radiopharmaceutical Consumption CAGR by Region
2.2 Radiopharmaceutical Segment by Type
2.2.1 Actinium-225
2.2.2 Lutetium-177
2.2.3 Radium-223
2.2.4 Holmium-166
2.2.5 Other
2.3 Radiopharmaceutical Consumption by Type
2.3.1 Global Radiopharmaceutical Consumption Market Share by Type (2015-2020)
2.3.2 Global Radiopharmaceutical Revenue and Market Share by Type (2015-2020)
2.3.3 Global Radiopharmaceutical Sale Price by Type (2015-2020)
2.4 Radiopharmaceutical Segment by Application
2.4.1 Oncology
2.4.2 Cardiology
2.4.3 Other
2.5 Radiopharmaceutical Consumption by Application
2.5.1 Global Radiopharmaceutical Consumption Market Share by Type (2015-2020)
2.5.2 Global Radiopharmaceutical Value and Market Share by Type (2015-2020)
2.5.3 Global Radiopharmaceutical Sale Price by Type (2015-2020)
3 Global Radiopharmaceutical by Company
3.1 Global Radiopharmaceutical Sales Market Share by Company
3.1.1 Global Radiopharmaceutical Sales by Company (2018-2020)
3.1.2 Global Radiopharmaceutical Sales Market Share by Company (2018-2020)
3.2 Global Radiopharmaceutical Revenue Market Share by Company
3.2.1 Global Radiopharmaceutical Revenue by Company (2018-2020)
3.2.2 Global Radiopharmaceutical Revenue Market Share by Company (2018-2020)
3.3 Global Radiopharmaceutical Sale Price by Company
3.4 Global Radiopharmaceutical Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Radiopharmaceutical Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Radiopharmaceutical Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Radiopharmaceutical by Regions
4.1 Radiopharmaceutical by Regions
4.2 Americas Radiopharmaceutical Consumption Growth
4.3 APAC Radiopharmaceutical Consumption Growth
4.4 Europe Radiopharmaceutical Consumption Growth
4.5 Middle East & Africa Radiopharmaceutical Consumption Growth
5 Americas
5.1 Americas Radiopharmaceutical Consumption by Countries
5.1.1 Americas Radiopharmaceutical Consumption by Countries (2015-2020)
5.1.2 Americas Radiopharmaceutical Value by Countries (2015-2020)
5.2 Americas Radiopharmaceutical Consumption by Type
5.3 Americas Radiopharmaceutical Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Radiopharmaceutical Consumption by Regions
6.1.1 APAC Radiopharmaceutical Consumption by Regions (2015-2020)
6.1.2 APAC Radiopharmaceutical Value by Regions (2015-2020)
6.2 APAC Radiopharmaceutical Consumption by Type
6.3 APAC Radiopharmaceutical Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Radiopharmaceutical by Countries
7.1.1 Europe Radiopharmaceutical Consumption by Countries (2015-2020)
7.1.2 Europe Radiopharmaceutical Value by Countries (2015-2020)
7.2 Europe Radiopharmaceutical Consumption by Type
7.3 Europe Radiopharmaceutical Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Radiopharmaceutical by Countries
8.1.1 Middle East & Africa Radiopharmaceutical Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Radiopharmaceutical Value by Countries (2015-2020)
8.2 Middle East & Africa Radiopharmaceutical Consumption by Type
8.3 Middle East & Africa Radiopharmaceutical Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Radiopharmaceutical Distributors
10.3 Radiopharmaceutical Customer
11 Global Radiopharmaceutical Market Forecast
11.1 Global Radiopharmaceutical Consumption Forecast (2021-2025)
11.2 Global Radiopharmaceutical Forecast by Regions
11.2.1 Global Radiopharmaceutical Forecast by Regions (2021-2025)
11.2.2 Global Radiopharmaceutical Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Radiopharmaceutical Forecast by Type
11.8 Global Radiopharmaceutical Forecast by Application
12 Key Players Analysis
12.1 Bracco Imaging
12.1.1 Company Information
12.1.2 Radiopharmaceutical Product Offered
12.1.3 Bracco Imaging Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Bracco Imaging Latest Developments
12.2 Jubilant Pharma
12.2.1 Company Information
12.2.2 Radiopharmaceutical Product Offered
12.2.3 Jubilant Pharma Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Jubilant Pharma Latest Developments
12.3 Bayer
12.3.1 Company Information
12.3.2 Radiopharmaceutical Product Offered
12.3.3 Bayer Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Bayer Latest Developments
12.4 Nordion
12.4.1 Company Information
12.4.2 Radiopharmaceutical Product Offered
12.4.3 Nordion Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Nordion Latest Developments
12.5 Triad Isotopes
12.5.1 Company Information
12.5.2 Radiopharmaceutical Product Offered
12.5.3 Triad Isotopes Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Triad Isotopes Latest Developments
12.6 Mallinckrodt
12.6.1 Company Information
12.6.2 Radiopharmaceutical Product Offered
12.6.3 Mallinckrodt Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Mallinckrodt Latest Developments
12.7 GE Healthcare
12.7.1 Company Information
12.7.2 Radiopharmaceutical Product Offered
12.7.3 GE Healthcare Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 GE Healthcare Latest Developments
12.8 Lantheus
12.8.1 Company Information
12.8.2 Radiopharmaceutical Product Offered
12.8.3 Lantheus Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Lantheus Latest Developments
12.9 China Isotope & Radiation
12.9.1 Company Information
12.9.2 Radiopharmaceutical Product Offered
12.9.3 China Isotope & Radiation Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 China Isotope & Radiation Latest Developments
12.10 IBA Group
12.10.1 Company Information
12.10.2 Radiopharmaceutical Product Offered
12.10.3 IBA Group Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 IBA Group Latest Developments
12.11 Eli Lilly
12.11.1 Company Information
12.11.2 Radiopharmaceutical Product Offered
12.11.3 Eli Lilly Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Eli Lilly Latest Developments
12.12 Dongcheng
12.12.1 Company Information
12.12.2 Radiopharmaceutical Product Offered
12.12.3 Dongcheng Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Dongcheng Latest Developments
12.13 SIEMENS
12.13.1 Company Information
12.13.2 Radiopharmaceutical Product Offered
12.13.3 SIEMENS Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 SIEMENS Latest Developments
12.14 Navidea
12.14.1 Company Information
12.14.2 Radiopharmaceutical Product Offered
12.14.3 Navidea Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Navidea Latest Developments
12.15 Advanced Accelerator Applications
12.15.1 Company Information
12.15.2 Radiopharmaceutical Product Offered
12.15.3 Advanced Accelerator Applications Radiopharmaceutical Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 Advanced Accelerator Applications Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Radiopharmaceutical Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Actinium-225
Table 5. Major Players of Lutetium-177
Table 6. Major Players of Radium-223
Table 7. Major Players of Holmium-166
Table 8. Major Players of Other
Table 9. Global Consumption Sales by Type (2015-2020)
Table 10. Global Radiopharmaceutical Consumption Market Share by Type (2015-2020)
Table 11. Global Radiopharmaceutical Revenue by Type (2015-2020) ($ million)
Table 12. Global Radiopharmaceutical Value Market Share by Type (2015-2020) ($ Millions)
Table 13. Global Radiopharmaceutical Sale Price by Type (2015-2020)
Table 14. Global Consumption Sales by Application (2015-2020)
Table 15. Global Radiopharmaceutical Consumption Market Share by Application (2015-2020)
Table 16. Global Radiopharmaceutical Value by Application (2015-2020)
Table 17. Global Radiopharmaceutical Value Market Share by Application (2015-2020)
Table 18. Global Radiopharmaceutical Sale Price by Application (2015-2020)
Table 19. Global Radiopharmaceutical Sales by Company (2017-2019) (M Doses)
Table 20. Global Radiopharmaceutical Sales Market Share by Company (2017-2019)
Table 21. Global Radiopharmaceutical Revenue by Company (2017-2019) ($ Millions)
Table 22. Global Radiopharmaceutical Revenue Market Share by Company (2017-2019)
Table 23. Global Radiopharmaceutical Sale Price by Company (2017-2019)
Table 24. Global Radiopharmaceutical Manufacturing Base Distribution and Sales Area by Manufacturers
Table 25. Players Radiopharmaceutical Products Offered
Table 26. Radiopharmaceutical Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 27. Global Radiopharmaceutical Consumption by Regions 2015-2020 (M Doses)
Table 28. Global Radiopharmaceutical Consumption Market Share by Regions 2015-2020
Table 29. Global Radiopharmaceutical Value by Regions 2015-2020 ($ Millions)
Table 30. Global Radiopharmaceutical Value Market Share by Regions 2015-2020
Table 31. Americas Radiopharmaceutical Consumption by Countries (2015-2020) (M Doses)
Table 32. Americas Radiopharmaceutical Consumption Market Share by Countries (2015-2020)
Table 33. Americas Radiopharmaceutical Value by Countries (2015-2020) ($ Millions)
Table 34. Americas Radiopharmaceutical Value Market Share by Countries (2015-2020)
Table 35. Americas Radiopharmaceutical Consumption by Type (2015-2020) (M Doses)
Table 36. Americas Radiopharmaceutical Consumption Market Share by Type (2015-2020)
Table 37. Americas Radiopharmaceutical Consumption by Application (2015-2020) (M Doses)
Table 38. Americas Radiopharmaceutical Consumption Market Share by Application (2015-2020)
Table 39. APAC Radiopharmaceutical Consumption by Countries (2015-2020) (M Doses)
Table 40. APAC Radiopharmaceutical Consumption Market Share by Countries (2015-2020)
Table 41. APAC Radiopharmaceutical Value by Regions (2015-2020) ($ Millions)
Table 42. APAC Radiopharmaceutical Value Market Share by Regions (2015-2020)
Table 43. APAC Radiopharmaceutical Consumption by Type (2015-2020) (M Doses)
Table 44. APAC Radiopharmaceutical Consumption Market Share by Type (2015-2020)
Table 45. APAC Radiopharmaceutical Consumption by Application (2015-2020) (M Doses)
Table 46. APAC Radiopharmaceutical Consumption Market Share by Application (2015-2020)
Table 47. Europe Radiopharmaceutical Consumption by Countries (2015-2020) (M Doses)
Table 48. Europe Radiopharmaceutical Consumption Market Share by Countries (2015-2020)
Table 49. Europe Radiopharmaceutical Value by Countries (2015-2020) ($ Millions)
Table 50. Europe Radiopharmaceutical Value Market Share by Countries (2015-2020)
Table 51. Europe Radiopharmaceutical Consumption by Type (2015-2020) (M Doses)
Table 52. Europe Radiopharmaceutical Consumption Market Share by Type (2015-2020)
Table 53. Europe Radiopharmaceutical Consumption by Application (2015-2020) (M Doses)
Table 54. Europe Radiopharmaceutical Consumption Market Share by Application (2015-2020)
Table 55. Middle East & Africa Radiopharmaceutical Consumption by Countries (2015-2020) (M Doses)
Table 56. Middle East & Africa Radiopharmaceutical Consumption Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Radiopharmaceutical Value by Countries (2015-2020) ($ Millions)
Table 58. Middle East & Africa Radiopharmaceutical Value Market Share by Countries (2015-2020)
Table 59. Middle East & Africa Radiopharmaceutical Consumption by Type (2015-2020) (M Doses)
Table 60. Middle East & Africa Radiopharmaceutical Consumption Market Share by Type (2015-2020)
Table 61. Middle East & Africa Radiopharmaceutical Consumption by Application (2015-2020) (M Doses)
Table 62. Middle East & Africa Radiopharmaceutical Consumption Market Share by Application (2015-2020)
Table 63. Radiopharmaceutical Distributors List
Table 64. Radiopharmaceutical Customer List
Table 65. Global Radiopharmaceutical Consumption Forecast by Countries (2021-2025) (M Doses)
Table 66. Global Radiopharmaceutical Consumption Market Forecast by Regions
Table 67. Global Radiopharmaceutical Value Forecast by Countries (2021-2025) ($ Millions)
Table 68. Global Radiopharmaceutical Value Market Share Forecast by Regions
Table 69. Global Radiopharmaceutical Consumption Forecast by Type (2021-2025) (M Doses)
Table 70. Global Radiopharmaceutical Consumption Market Share Forecast by Type (2021-2025)
Table 71. Global Radiopharmaceutical Value Forecast by Type (2021-2025) ($ Millions)
Table 72. Global Radiopharmaceutical Value Market Share Forecast by Type (2021-2025)
Table 73. Global Radiopharmaceutical Consumption Forecast by Application (2021-2025) (M Doses)
Table 74. Global Radiopharmaceutical Consumption Market Share Forecast by Application (2021-2025)
Table 75. Global Radiopharmaceutical Value Forecast by Application (2021-2025) ($ Millions)
Table 76. Global Radiopharmaceutical Value Market Share Forecast by Application (2021-2025)
Table 77. Bracco Imaging Product Offered
Table 78. Bracco Imaging Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 79. Bracco Imaging Main Business
Table 80. Bracco Imaging Latest Developments
Table 81. Bracco Imaging Basic Information, Company Total Revenue (in $ million), Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 82. Jubilant Pharma Product Offered
Table 83. Jubilant Pharma Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 84. Jubilant Pharma Main Business
Table 85. Jubilant Pharma Latest Developments
Table 86. Jubilant Pharma Basic Information, Company Total Revenue (in $ million), Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 87. Bayer Product Offered
Table 88. Bayer Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 89. Bayer Main Business
Table 90. Bayer Latest Developments
Table 91. Bayer Basic Information, Company Total Revenue (in $ million), Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 92. Nordion Product Offered
Table 93. Nordion Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 94. Nordion Main Business
Table 95. Nordion Latest Developments
Table 96. Nordion Basic Information, Company Total Revenue (in $ million), Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 97. Triad Isotopes Product Offered
Table 98. Triad Isotopes Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 99. Triad Isotopes Main Business
Table 100. Triad Isotopes Latest Developments
Table 101. Triad Isotopes Basic Information, Company Total Revenue (in $ million), Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 102. Mallinckrodt Product Offered
Table 103. Mallinckrodt Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 104. Mallinckrodt Main Business
Table 105. Mallinckrodt Latest Developments
Table 106. Mallinckrodt Basic Information, Company Total Revenue (in $ million), Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 107. GE Healthcare Product Offered
Table 108. GE Healthcare Basic Information, Company Total Revenue (in $ million), Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 109. GE Healthcare Main Business
Table 110. GE Healthcare Latest Developments
Table 111. GE Healthcare Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 112. Lantheus Product Offered
Table 113. Lantheus Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 114. Lantheus Main Business
Table 115. Lantheus Latest Developments
Table 116. Lantheus Basic Information, Company Total Revenue (in $ million), Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 117. China Isotope & Radiation Product Offered
Table 118. China Isotope & Radiation Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 119. China Isotope & Radiation Main Business
Table 120. China Isotope & Radiation Latest Developments
Table 121. China Isotope & Radiation Basic Information, Company Total Revenue (in $ million), Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 122. IBA Group Product Offered
Table 123. IBA Group Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 124. IBA Group Main Business
Table 125. IBA Group Latest Developments
Table 126. IBA Group Basic Information, Company Total Revenue (in $ million), Radiopharmaceutical Manufacturing Base, Sales Area and Its Competitors
Table 127. Eli Lilly Product Offered
Table 128. Eli Lilly Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 129. Eli Lilly Main Business
Table 130. Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 131. Eli Lilly Latest Developments
Table 132. Dongcheng Product Offered
Table 133. Dongcheng Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 134. Dongcheng Main Business
Table 135. Dongcheng Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 136. Dongcheng Latest Developments
Table 137. SIEMENS Product Offered
Table 138. SIEMENS Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 139. SIEMENS Main Business
Table 140. SIEMENS Latest Developments
Table 141. SIEMENS Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 142. Navidea Product Offered
Table 143. Navidea Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 144. Navidea Main Business
Table 145. Navidea Latest Developments
Table 146. Navidea Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 147. Advanced Accelerator Applications Product Offered
Table 148. Advanced Accelerator Applications Radiopharmaceutical Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E)
Table 149. Advanced Accelerator Applications Main Business
Table 150. Advanced Accelerator Applications Latest Developments
Table 151. Advanced Accelerator Applications Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Radiopharmaceutical
Figure 2. Radiopharmaceutical Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Radiopharmaceutical Consumption Growth Rate 2015-2025 (M Doses)
Figure 5. Global Radiopharmaceutical Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Actinium-225
Figure 7. Product Picture of Lutetium-177
Figure 8. Product Picture of Radium-223
Figure 9. Product Picture of Holmium-166
Figure 10. Product Picture of Other
Figure 11. Global Radiopharmaceutical Consumption Market Share by Type (2015-2020)
Figure 12. Global Radiopharmaceutical Value Market Share by Type (2015-2020)
Figure 13. Radiopharmaceutical Consumed in Oncology
Figure 14. Global Radiopharmaceutical Market: Oncology (2015-2020) (M Doses)
Figure 15. Global Radiopharmaceutical Market: Oncology (2015-2020) ($ Millions)
Figure 16. Radiopharmaceutical Consumed in Cardiology
Figure 17. Global Radiopharmaceutical Market: Cardiology (2015-2020) (M Doses)
Figure 18. Global Radiopharmaceutical Market: Cardiology (2015-2020) ($ Millions)
Figure 19. Radiopharmaceutical Consumed in Other
Figure 20. Global Radiopharmaceutical Market: Other (2015-2020) (M Doses)
Figure 21. Global Radiopharmaceutical Market: Other (2015-2020) ($ Millions)
Figure 22. Global Radiopharmaceutical Consumption Market Share by Application (2015-2020)
Figure 23. Global Radiopharmaceutical Value Market Share by Application (2015-2020)
Figure 24. Global Radiopharmaceutical Sales Market Share by Company in 2017
Figure 25. Global Radiopharmaceutical Sales Market Share by Company in 2019
Figure 26. Global Radiopharmaceutical Revenue Market Share by Company in 2017
Figure 27. Global Radiopharmaceutical Revenue Market Share by Company in 2019
Figure 28. Global Radiopharmaceutical Sale Price by Company in 2019
Figure 29. Global Radiopharmaceutical Consumption Market Share by Regions 2015-2020
Figure 30. Global Radiopharmaceutical Value Market Share by Regions 2015-2020
Figure 31. Americas Radiopharmaceutical Consumption 2015-2020 (M Doses)
Figure 32. Americas Radiopharmaceutical Value 2015-2020 ($ Millions)
Figure 33. APAC Radiopharmaceutical Consumption 2015-2020 (M Doses)
Figure 34. APAC Radiopharmaceutical Value 2015-2020 ($ Millions)
Figure 35. Europe Radiopharmaceutical Consumption 2015-2020 (M Doses)
Figure 36. Europe Radiopharmaceutical Value 2015-2020 ($ Millions)
Figure 37. Middle East & Africa Radiopharmaceutical Consumption 2015-2020 (M Doses)
Figure 38. Middle East & Africa Radiopharmaceutical Value 2015-2020 ($ Millions)
Figure 39. Americas Radiopharmaceutical Consumption Market Share by Countries in 2019
Figure 40. Americas Radiopharmaceutical Value Market Share by Countries in 2019
Figure 41. Americas Radiopharmaceutical Consumption Market Share by Type in 2019
Figure 42. Americas Radiopharmaceutical Consumption Market Share by Application in 2019
Figure 43. United States Radiopharmaceutical Consumption Growth 2015-2020 (M Doses)
Figure 44. United States Radiopharmaceutical Value Growth 2015-2020 ($ Millions)
Figure 45. Canada Radiopharmaceutical Consumption Growth 2015-2020 (M Doses)
Figure 46. Canada Radiopharmaceutical Value Growth 2015-2020 ($ Millions)
Figure 47. Mexico Radiopharmaceutical Consumption Growth 2015-2020 (M Doses)
Figure 48. Mexico Radiopharmaceutical Value Growth 2015-2020 ($ Millions)
Figure 49. APAC Radiopharmaceutical Consumption Market Share by Countries in 2019
Figure 50. APAC Radiopharmaceutical Value Market Share by Regions in 2019
Figure 51. APAC Radiopharmaceutical Consumption Market Share by Type in 2019
Figure 52. APAC Radiopharmaceutical Consumption Market Share by Application in 2019
Figure 53. China Radiopharmaceutical Consumption Growth 2015-2020 (M Doses)
Figure 54. China Radiopharmaceutical Value Growth 2015-2020 ($ Millions)
Figure 55. Japan Radiopharmaceutical Consumption Growth 2015-2020 (M Doses)
Figure 56. Japan Radiopharmaceutical Value Growth 2015-2020 ($ Millions)
Figure 57. Korea Radiopharmaceutical Consumption Growth 2015-2020 (M Doses)
Figure 58. Korea Radiopharmaceutical Value Growth 2015-2020 ($ Millions)
Figure 59. Southeast Asia Radiopharmaceutical Consumption Growth 2015-2020 (M Doses)
Figure 60. Southeast Asia Radiopharmaceutical Value Growth 2015-2020 ($ Millions)
Figure 61. India Radiopharmaceutical Consumption Growth 2015-2020 (M Doses)
Figure 62. India Radiopharmaceutical Value Growth 2015-2020 ($ Millions)
Figure 63. Australia Radiopharmaceutical Consumption Growth 2015-2020 (M Doses)
Figure 64. Australia Radiopharmaceutical Value Growth 2015-2020 ($ Millions)
Figure 65. Europe Radiopharmaceutical Consumption Market Share by Countries in 2019
Figure 66. Europe Radiopharmaceutical Value Market Share by Countries in 2019
Figure 67. Europe Radiopharmaceutical Consumption Market Share by Type in 2019
Figure 68. Europe Radiopharmaceutical Consumption Market Share by Application in 2019
Figure 69. Germany Radiopharmaceutical Consumption Growth 2015-2020 (M Doses)
Figure 70. Germany Radiopharmaceutical Value Growth 2015-2020 ($ Millions)
Figure 71. France Radiopharmaceutical Consumption Growth 2015-2020 (M Doses)
Figure 72. France Radiopharmaceutical Value Growth 2015-2020 ($ Millions)
Figure 73. UK Radiopharmaceutical Consumption Growth 2015-2020 (M Doses)
Figure 74. UK Radiopharmaceutical Value Growth 2015-2020 ($ Millions)
Figure 75. Italy Radiopharmaceutical Consumption Growth 2015-2020 (M Doses)
Figure 76. Italy Radiopharmaceutical Value Growth 2015-2020 ($ Millions)
Figure 77. Russia Radiopharmaceutical Consumption Growth 2015-2020 (M Doses)
Figure 78. Russia Radiopharmaceutical Value Growth 2015-2020 ($ Millions)
Figure 79. Middle East & Africa Radiopharmaceutical Consumption Market Share by Countries in 2019
Figure 80. Middle East & Africa Radiopharmaceutical Value Market Share by Countries in 2019
Figure 81. Middle East & Africa Radiopharmaceutical Consumption Market Share by Type in 2019
Figure 82. Middle East & Africa Radiopharmaceutical Consumption Market Share by Application in 2019
Figure 83. Egypt Radiopharmaceutical Consumption Growth 2015-2020 (M Doses)
Figure 84. Egypt Radiopharmaceutical Value Growth 2015-2020 ($ Millions)
Figure 85. South Africa Radiopharmaceutical Consumption Growth 2015-2020 (M Doses)
Figure 86. South Africa Radiopharmaceutical Value Growth 2015-2020 ($ Millions)
Figure 87. Israel Radiopharmaceutical Consumption Growth 2015-2020 (M Doses)
Figure 88. Israel Radiopharmaceutical Value Growth 2015-2020 ($ Millions)
Figure 89. Turkey Radiopharmaceutical Consumption Growth 2015-2020 (M Doses)
Figure 90. Turkey Radiopharmaceutical Value Growth 2015-2020 ($ Millions)
Figure 91. GCC Countries Radiopharmaceutical Consumption Growth 2015-2020 (M Doses)
Figure 92. GCC Countries Radiopharmaceutical Value Growth 2015-2020 ($ Millions)
Figure 93. Global Radiopharmaceutical Consumption Growth Rate Forecast (2021-2025) (M Doses)
Figure 94. Global Radiopharmaceutical Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 95. Americas Radiopharmaceutical Consumption 2021-2025 (M Doses)
Figure 96. Americas Radiopharmaceutical Value 2021-2025 ($ Millions)
Figure 97. APAC Radiopharmaceutical Consumption 2021-2025 (M Doses)
Figure 98. APAC Radiopharmaceutical Value 2021-2025 ($ Millions)
Figure 99. Europe Radiopharmaceutical Consumption 2021-2025 (M Doses)
Figure 100. Europe Radiopharmaceutical Value 2021-2025 ($ Millions)
Figure 101. Middle East & Africa Radiopharmaceutical Consumption 2021-2025 (M Doses)
Figure 102. Middle East & Africa Radiopharmaceutical Value 2021-2025 ($ Millions)
Figure 103. United States Radiopharmaceutical Consumption 2021-2025 (M Doses)
Figure 104. United States Radiopharmaceutical Value 2021-2025 ($ Millions)
Figure 105. Canada Radiopharmaceutical Consumption 2021-2025 (M Doses)
Figure 106. Canada Radiopharmaceutical Value 2021-2025 ($ Millions)
Figure 107. Mexico Radiopharmaceutical Consumption 2021-2025 (M Doses)
Figure 108. Mexico Radiopharmaceutical Value 2021-2025 ($ Millions)
Figure 109. Brazil Radiopharmaceutical Consumption 2021-2025 (M Doses)
Figure 110. Brazil Radiopharmaceutical Value 2021-2025 ($ Millions)
Figure 111. China Radiopharmaceutical Consumption 2021-2025 (M Doses)
Figure 112. China Radiopharmaceutical Value 2021-2025 ($ Millions)
Figure 113. Japan Radiopharmaceutical Consumption 2021-2025 (M Doses)
Figure 114. Japan Radiopharmaceutical Value 2021-2025 ($ Millions)
Figure 115. Korea Radiopharmaceutical Consumption 2021-2025 (M Doses)
Figure 116. Korea Radiopharmaceutical Value 2021-2025 ($ Millions)
Figure 117. Southeast Asia Radiopharmaceutical Consumption 2021-2025 (M Doses)
Figure 118. Southeast Asia Radiopharmaceutical Value 2021-2025 ($ Millions)
Figure 119. India Radiopharmaceutical Consumption 2021-2025 (M Doses)
Figure 120. India Radiopharmaceutical Value 2021-2025 ($ Millions)
Figure 121. Australia Radiopharmaceutical Consumption 2021-2025 (M Doses)
Figure 122. Australia Radiopharmaceutical Value 2021-2025 ($ Millions)
Figure 123. Germany Radiopharmaceutical Consumption 2021-2025 (M Doses)
Figure 124. Germany Radiopharmaceutical Value 2021-2025 ($ Millions)
Figure 125. France Radiopharmaceutical Consumption 2021-2025 (M Doses)
Figure 126. France Radiopharmaceutical Value 2021-2025 ($ Millions)
Figure 127. UK Radiopharmaceutical Consumption 2021-2025 (M Doses)
Figure 128. UK Radiopharmaceutical Value 2021-2025 ($ Millions)
Figure 129. Italy Radiopharmaceutical Consumption 2021-2025 (M Doses)
Figure 130. Italy Radiopharmaceutical Value 2021-2025 ($ Millions)
Figure 131. Russia Radiopharmaceutical Consumption 2021-2025 (M Doses)
Figure 132. Russia Radiopharmaceutical Value 2021-2025 ($ Millions)
Figure 133. Spain Radiopharmaceutical Consumption 2021-2025 (M Doses)
Figure 134. Spain Radiopharmaceutical Value 2021-2025 ($ Millions)
Figure 135. Egypt Radiopharmaceutical Consumption 2021-2025 (M Doses)
Figure 136. Egypt Radiopharmaceutical Value 2021-2025 ($ Millions)
Figure 137. South Africa Radiopharmaceutical Consumption 2021-2025 (M Doses)
Figure 138. South Africa Radiopharmaceutical Value 2021-2025 ($ Millions)
Figure 139. Israel Radiopharmaceutical Consumption 2021-2025 (M Doses)
Figure 140. Israel Radiopharmaceutical Value 2021-2025 ($ Millions)
Figure 141. Turkey Radiopharmaceutical Consumption 2021-2025 (M Doses)
Figure 142. Turkey Radiopharmaceutical Value 2021-2025 ($ Millions)
Figure 143. GCC Countries Radiopharmaceutical Consumption 2021-2025 (M Doses)
Figure 144. GCC Countries Radiopharmaceutical Value 2021-2025 ($ Millions)
Figure 145. Bracco Imaging Radiopharmaceutical Market Share (2018-2020)
Figure 146. Jubilant Pharma Radiopharmaceutical Market Share (2018-2020)
Figure 147. Bayer Radiopharmaceutical Market Share (2018-2020)
Figure 148. Nordion Radiopharmaceutical Market Share (2018-2020)
Figure 149. Triad Isotopes Radiopharmaceutical Market Share (2018-2020)
Figure 150. Mallinckrodt Radiopharmaceutical Market Share (2018-2020)
Figure 151. GE Healthcare Radiopharmaceutical Market Share (2018-2020)
Figure 152. Lantheus Radiopharmaceutical Market Share (2018-2020)
Figure 153. China Isotope & Radiation Radiopharmaceutical Market Share (2018-2020)
Figure 154. IBA Group Radiopharmaceutical Market Share (2018-2020)
Figure 155. Eli Lilly Radiopharmaceutical Market Share (2018-2020)
Figure 156. Dongcheng Radiopharmaceutical Market Share (2018-2020)
Figure 157. SIEMENS Radiopharmaceutical Market Share (2018-2020)
Figure 158. Navidea Radiopharmaceutical Market Share (2018-2020)
Figure 159. Advanced Accelerator Applications Radiopharmaceutical Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets